2i Maintains a Naive Ground State in ESCs Through Two Distinct Epigenetic Mechanisms

Overview

Journal Stem Cell Reports

Publisher Cell Press

Specialty Cell Biology

Date 2017 May 2

PMID 28457889

Citations 24

Authors

Ye-Ji Sim

Min-Seong Kim

Abeer Nayfeh

Ye-Jin Yun

Su-Jin Kim

Kyung-Tae Park

Chang-Hoon Kim

Kye-Seong Kim

Affiliations

Soon will be listed here.

Abstract

Mouse embryonic stem cells (ESCs) are maintained in serum with leukemia inhibitory factor (LIF) to maintain self-renewal and pluripotency. Recently, a 2i culture method was reported using a combination of MEK inhibition (MEKi) and GSK3 inhibition (GSK3i) with LIF to maintain ESCs in a naive ground state. How 2i maintains a ground state of ESCs remains elusive. Here we show that MEKi and GSK3i maintain the ESC ground state by downregulating global DNA methylation through two distinct mechanisms. MEK1 phosphorylates JMJD2C for ubiquitin-mediated protein degradation. Therefore, MEKi increased JMJD2C protein levels but decreased DNMT3 expression. JMJD2C promotes TET1 activity to increase 5-hydroxymethylcytosine (5hmC) levels. GSK3i suppressed DNMT3 expression, thereby decreasing DNA methylation without affecting 5hmC levels. Furthermore, 2i increased PRDM14 expression to inhibit DNMT3A/B protein expression by promoting G9a-mediated DNMT3A/B protein degradation. Collectively, 2i allows ESCs to maintain a naive ground state through JMJD2C-dependent TET1 activation and PRDM14/G9a-mediated DNMT3A/B protein degradation.

Citing Articles

Vitamin C and MEK Inhibitor PD0325901 Synergistically Promote Oligodendrocytes Generation by Promoting DNA Demethylation.

Ren X, Yang Y, Wang M, Yuan Q, Suo N, Xie X Molecules. 2025; 29(24.

PMID: 39770028 PMC: 11677943. DOI: 10.3390/molecules29245939.

ZBTB24 is a conserved multifaceted transcription factor at genes and centromeres that governs the DNA methylation state and expression of satellite repeats.

Grillo G, Boyarchuk E, Mihic S, Ivkovic I, Bertrand M, Jouneau A Hum Mol Genet. 2024; 34(2):161-177.

PMID: 39562305 PMC: 11780882. DOI: 10.1093/hmg/ddae163.

A conserved transcription factor regulatory program promotes tendon fate.

Niu X, Melendez D, Raj S, Cai J, Senadeera D, Mandelbaum J Dev Cell. 2024; 59(23):3106-3123.e12.

PMID: 39216481 PMC: 11781300. DOI: 10.1016/j.devcel.2024.08.006.

DNMT1 can induce primary germ layer differentiation through de novo DNA methylation.

Ito T, Kubiura-Ichimaru M, Miura F, Tajima S, Surani M, Ito T Genes Cells. 2024; 29(7):549-566.

PMID: 38811355 PMC: 11447926. DOI: 10.1111/gtc.13130.

Hallmarks of totipotent and pluripotent stem cell states.

Du P, Wu J Cell Stem Cell. 2024; 31(3):312-333.

PMID: 38382531 PMC: 10939785. DOI: 10.1016/j.stem.2024.01.009.

References

Atlasi Y, Noori R, Gaspar C, Franken P, Sacchetti A, Rafati H . Wnt signaling regulates the lineage differentiation potential of mouse embryonic stem cells through Tcf3 down-regulation. PLoS Genet. 2013; 9(5):e1003424. PMC: 3642041. DOI: 10.1371/journal.pgen.1003424. View

Chen J, Liu H, Liu J, Qi J, Wei B, Yang J . H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs. Nat Genet. 2012; 45(1):34-42. DOI: 10.1038/ng.2491. View

Cacace A, Michaud N, Therrien M, Mathes K, Copeland T, Rubin G . Identification of constitutive and ras-inducible phosphorylation sites of KSR: implications for 14-3-3 binding, mitogen-activated protein kinase binding, and KSR overexpression. Mol Cell Biol. 1998; 19(1):229-40. PMC: 83881. DOI: 10.1128/MCB.19.1.229. View

Baylin S . DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol. 2005; 2 Suppl 1:S4-11. DOI: 10.1038/ncponc0354. View

Habibi E, Brinkman A, Arand J, Kroeze L, Kerstens H, Matarese F . Whole-genome bisulfite sequencing of two distinct interconvertible DNA methylomes of mouse embryonic stem cells. Cell Stem Cell. 2013; 13(3):360-9. DOI: 10.1016/j.stem.2013.06.002. View

Smith A, Heath J, Donaldson D, Wong G, Moreau J, Stahl M . Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature. 1988; 336(6200):688-90. DOI: 10.1038/336688a0. View

Rathert P, Dhayalan A, Murakami M, Zhang X, Tamas R, Jurkowska R . Protein lysine methyltransferase G9a acts on non-histone targets. Nat Chem Biol. 2008; 4(6):344-6. PMC: 2696268. DOI: 10.1038/nchembio.88. View

Marks H, Stunnenberg H . Transcription regulation and chromatin structure in the pluripotent ground state. Biochim Biophys Acta. 2013; 1839(3):129-37. DOI: 10.1016/j.bbagrm.2013.09.005. View

Pedersen M, Agger K, Laugesen A, Johansen J, Cloos P, Christensen J . The demethylase JMJD2C localizes to H3K4me3-positive transcription start sites and is dispensable for embryonic development. Mol Cell Biol. 2014; 34(6):1031-45. PMC: 3958041. DOI: 10.1128/MCB.00864-13. View

10.

Tsumura A, Hayakawa T, Kumaki Y, Takebayashi S, Sakaue M, Matsuoka C . Maintenance of self-renewal ability of mouse embryonic stem cells in the absence of DNA methyltransferases Dnmt1, Dnmt3a and Dnmt3b. Genes Cells. 2006; 11(7):805-14. DOI: 10.1111/j.1365-2443.2006.00984.x. View

11.

Miki T, Yasuda S, Kahn M . Wnt/β-catenin signaling in embryonic stem cell self-renewal and somatic cell reprogramming. Stem Cell Rev Rep. 2011; 7(4):836-46. DOI: 10.1007/s12015-011-9275-1. View

12.

Subramaniam D, Thombre R, Dhar A, Anant S . DNA methyltransferases: a novel target for prevention and therapy. Front Oncol. 2014; 4:80. PMC: 4013461. DOI: 10.3389/fonc.2014.00080. View

13.

Chen T, Ueda Y, Xie S, Li E . A novel Dnmt3a isoform produced from an alternative promoter localizes to euchromatin and its expression correlates with active de novo methylation. J Biol Chem. 2002; 277(41):38746-54. DOI: 10.1074/jbc.M205312200. View

14.

Leitch H, McEwen K, Turp A, Encheva V, Carroll T, Grabole N . Naive pluripotency is associated with global DNA hypomethylation. Nat Struct Mol Biol. 2013; 20(3):311-6. PMC: 3591483. DOI: 10.1038/nsmb.2510. View

15.

Dillon S, Zhang X, Trievel R, Cheng X . The SET-domain protein superfamily: protein lysine methyltransferases. Genome Biol. 2005; 6(8):227. PMC: 1273623. DOI: 10.1186/gb-2005-6-8-227. View

16.

Klose R, Yamane K, Bae Y, Zhang D, Erdjument-Bromage H, Tempst P . The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36. Nature. 2006; 442(7100):312-6. DOI: 10.1038/nature04853. View

17.

Huang W, Lv X, Liu C, Zha Z, Zhang H, Jiang Y . The N-terminal phosphodegron targets TAZ/WWTR1 protein for SCFβ-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition. J Biol Chem. 2012; 287(31):26245-53. PMC: 3406709. DOI: 10.1074/jbc.M112.382036. View

18.

Whetstine J, Nottke A, Lan F, Huarte M, Smolikov S, Chen Z . Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell. 2006; 125(3):467-81. DOI: 10.1016/j.cell.2006.03.028. View

19.

Zhang X, Peterson K, Liu X, McMahon A, Ohba S . Gene regulatory networks mediating canonical Wnt signal-directed control of pluripotency and differentiation in embryo stem cells. Stem Cells. 2013; 31(12):2667-79. PMC: 3830733. DOI: 10.1002/stem.1371. View

20.

Marks H, Kalkan T, Menafra R, Denissov S, Jones K, Hofemeister H . The transcriptional and epigenomic foundations of ground state pluripotency. Cell. 2012; 149(3):590-604. PMC: 3398752. DOI: 10.1016/j.cell.2012.03.026. View